Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke (ACTION)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by Biogen Idec
Sponsor:
Information provided by (Responsible Party):
Biogen Idec
ClinicalTrials.gov Identifier:
NCT01955707
First received: September 30, 2013
Last updated: November 14, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)